Product
Topical Hidroquinone
1 clinical trial
1 indication
Indication
MelasmaClinical trial
The Effectiveness of 3% Topical Tranexamic Acid Compared to 4% Topical Hydroquinone as Therapy of MelasmaStatus: Active (not recruiting), Estimated PCD: 2023-09-01